VSIR and breast cancer: In contrast to that study, this study found that VISTA was mainly expressed in CD68+ macrophages (mean = 32.58%) in breast cancer and in CD4+ T cells (mean = 4.97%), and lower levels of VISTA were found in CD8+ cytotoxic cells (mean = 4.48%) (Figure 4).